Evidence map›Paper›PMID 32564467›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2020

Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID-19 Severity.

Daniel Bertin, Alexandre Brodovitch, Abdou Beziane, Sylvia Hug, Afaf Bouamri, Jean Louis Mege, Xavier Heim, Nathalie Bardin

Open access · bronzeAbstract readLetter
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 5 pooled it
1.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 5 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. COVID-19 and antiphospholipid antibodies.Best practice & research. Clinical haematology · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Daniel BertinHôpital de la Conception, AP-HM, Aix-Marseille Université, CNRS, UMR 7051 and UMR, 3916.ORCID 0000-0001-7172-8865
Alexandre BrodovitchHôpital de la Conception, AP-HM.
Abdou BezianeHôpital de la Conception, AP-HM.
Sylvia HugHôpital de la Conception, AP-HM.
Afaf BouamriHôpital de la Conception, AP-HM.
Jean Louis MegeHôpital de la Conception, AP-HM, Aix-Marseille Université, IRD and Méditerranée Infection.
Xavier HeimHôpital de la Conception, AP-HM, Aix Marseille Université, Center for CardioVascular and Nutrition Research and INSERM UMRS 1263, Marseille, France.
Nathalie BardinHôpital de la Conception, AP-HM, Aix Marseille Université, Center for CardioVascular and Nutrition Research and INSERM UMRS 1263, Marseille, France.
Assistance Publique Hôpitaux de Marseille · FRAix-Marseille Université · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAged, 80 and overAntibodies, AnticardiolipinCOVID-19FemaleHumansImmunoglobulin GMaleMiddle AgedRisk FactorsSeverity of Illness IndexAntibodies, AnticardiolipinImmunoglobulin G

Identifiers

PMID32564467
PMCPMC7323091
OpenAlexW3035882439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.